New £1.65m gene-editing therapy gives hope to some blood disorder patients

The UK has approximately 17,500 individuals living with sickle cell disease, a condition particularly prevalent amongst those of African or Caribbean descent, causing symptoms such as intense pain, life-threatening infections, and anaemia

Go to Source
Author: Ella Pickover